Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
24 results
- 1상완료· Chronic Kidney FailureA Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)
리드: 머크(MSD)
- 1상완료· Diabetes Mellitus, Type 2A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)
리드: 머크(MSD)
- 해당없음완료· Vaccine HesitancyImproving Vaccine Acceptance Through EHR Integrated Patient- and Provider-Facing Decision Support
협력: 머크(MSD)
- 해당없음완료· Heart FailureTailored Electronic Intervention to Improve Therapy in a Diverse Cohort of Patients With Heart Failure
협력: 머크(MSD)
- 1상완료· Hepatic Impairment (HI)A Study of Nemtabrutinib in Participants With Moderate Hepatic Impairment (MK-1026-015)
리드: 머크(MSD)
- 1상완료· Neoplasm MetastasisA Study of MK-6837 as a Monotherapy and Combination Therapy in Participants With Advanced/Metastatic Solid Tumors (MK-6837-001)
리드: 머크(MSD)
- 4상완료· Intestinal DiseaseNeuromuscular Blockade Comparison for GI-2 Recovery After Bowel Resection
협력: 머크(MSD)
- 2상완료· Ovarian CarcinosarcomaEPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine Carcinosarcoma
협력: 머크(MSD)
- 2상완료· Esophagogastric AdenocarcinomaEvaluating Pembrolizumab, Trastuzumab and FLOT as Perioperative Treatment of HER2-positive, Localized Esophagogastric Adenocarcinoma
협력: 머크(MSD)
- 2상완료· Metastatic Uveal MelanomaEfficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME)
협력: 머크(MSD)
- 2상완료· Non-squamous Non-small-cell Lung CancerLenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With EGFR Mutations
협력: 머크(MSD)
- 3상완료· Carcinoma, Non-Small-Cell LungStudy of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006)
리드: 머크(MSD)
- 2상완료· Squamous Cell Carcinoma of LarynxStudy of a Pembrolizumab-based Organ Preservation Strategy for Locally Advanced Larynx Cancers
협력: 머크(MSD)
- 2상완료· Advanced Gastric AdenocarcinomaPaclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma
협력: 머크(MSD)
- 3상완료· Esophageal Squamous Cell Carcinoma (ESCC)Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)
리드: 머크(MSD)
- 1상완료· Recurrent GlioblastomaPembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma
협력: 머크(MSD)
- 2상완료· Metastatic Malignant Neoplasm in the LiverPembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases
협력: 머크(MSD)
- 1/2상완료· Melanoma and Other Malignant Neoplasms of SkinStudy of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss
협력: GSK, 머크(MSD)
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.